This study will compare an investigational mRNA flu vaccine with a licensed flu vaccine in adults 65 years of age and older. Participants will receive one inje…

Influenza, Human

~Estimated

~$10 – $7,500

GlaxoSmithKlineNCT07805707

Phase 1

A Phase 1, Observer-Blind, Randomized, Controlled Study to Evaluate the Safety and Immunogenicity of an Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults

This early-stage study will look at a new mRNA vaccine that combines defenses against both seasonal flu and COVID-19 in terms of its safety and how it builds p…

Influenza, Human+COVID-19

~Estimated

~$10 – $7,500

GlaxoSmithKlineNCT07464314

Phase 4

Characterization of Humoral and Cellular Immune Responses Elicited by Influenza Vaccination in Healthy Adults

Cellular and humoral immune responses before and after seasonal influenza vaccination will be assessed. Each year, up to 100 participants will be enrolled. To …

Influenza, Human

~Estimated

~$10 – $6,250

University of PennsylvaniaNCT05108818